SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (111)11/3/2003 4:30:35 PM
From: A.J. Mullen  Read Replies (1) of 411
 
Clearly there's a lot I don't know about the approval process. I thought an AC meeting was the norm. Is that not so?

I remember the company being asked about the Qt interval at H&Q in January. The response was that they expected questions to be asked, but that the prolongation was small compared to the observed range. I wasn't convinced by that; a bias that is small compared to the observed variance can still affect the expectation substantially. On the otherhand, maybe the interval between firing and recovery has little importance?

Ashley
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News